
|Videos|April 18, 2017
Advanced Squamous Non-Small Cell Lung Cancer: Case 1
Advanced Squamous Non-Small Cell Lung Cancer
Advertisement
November 2016
- An 81-year-old male presents to his physician with symptoms of cough, hemoptysis, and fatigue requiring frequent rest during the day
- PMH includes hypercholesterolemia, controlled on simvastatin and hypertension, controlled on a calcium channel blocker; mild osteoarthritis
- He has no history of smoking
- The patient is physically active and plays golf several days per week
- CT of the chest revealed a solid cystic mass in the left upper lobe and lymphadenopathy in the left hilar and bilateral mediastinal nodes
- PET/CT imaging showed 18F-FDG uptake in the lung mass, left hilar and both mediastinal lymph nodes
- Bronchoscopy and transbronchial lung biopsy were performed
- Pathology showed grade 3 squamous cell carcinoma of the lung
- Genetic testing was negative for known driver mutations
- PD-L1 testing by IHC showed expression in 65% of cells
- The patient was started on therapy with pembrolizumab
- Follow up imaging at 3 months showed stable disease
April 2017
- After 5 months on immunotherapy, the patient was hospitalized after having a seizure. He reported worsening fatigue and cough for 1 month
- CT showed increased size of the left upper lobe pulmonary mass
- Brain imaging showed several small intracranial lesions
- WBRT was started
- Immunotherapy was discontinued and the patient was started on carboplatin and nab-paclitaxel
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
4
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
5







































